GDTC
CytoMed Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$0.98
+10.61%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 80.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.26x
- Price / sales
- 23.02x
- Price / cash flow
- -2.75x
Enterprise value
- Enterprise value
- $10.6M
- EV / sales
- 20.99x
- EV / EBITDA
- -2.56x
- EV / EBIT
- -3.12x
- Market cap
- $11.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025